[HTML][HTML] Consensus on molecular imaging and theranostics in neuroendocrine neoplasms

V Ambrosini, J Kunikowska, E Baudin, L Bodei… - European journal of …, 2021 - Elsevier
Nuclear medicine plays an increasingly important role in the management neuroendocrine
neoplasms (NEN). Somatostatin analogue (SSA)-based positron emission …

Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA

MF Bozkurt, I Virgolini, S Balogova, M Beheshti… - European journal of …, 2017 - Springer
Abstract Purpose & Methods Neuroendocrine neoplasms are a heterogenous group of
tumours, for which nuclear medicine plays an important role in the diagnostic work-up as …

68Ga-DOTATATE PET/CT for the early prediction of response to somatostatin receptor–mediated radionuclide therapy in patients with well-differentiated …

AR Haug, CJ Auernhammer, B Wängler… - Journal of nuclear …, 2010 - Soc Nuclear Med
We aimed to evaluate 68Ga-DOTATATE PET/CT for the early prediction of time to
progression and clinical outcome after a first cycle of peptide receptor radionuclide treatment …

[HTML][HTML] PET with different radiopharmaceuticals in neuroendocrine neoplasms: An umbrella review of published meta-analyses

G Treglia, R Sadeghi, F Giovinazzo, F Galiandro… - Cancers, 2021 - mdpi.com
Simple Summary Functional imaging methods and, in particular, positron emission
tomography (PET) using several radiopharmaceuticals may play a pivotal role in patients …

The Utility of 68Ga-DOTATATE Positron-Emission Tomography/Computed Tomography in the Diagnosis, Management, Follow-Up and Prognosis of Neuroendocrine …

A Tirosh, E Kebebew - Future Oncology, 2017 - Taylor & Francis
Neuroendocrine tumors (NETs) are rare neoplasms that emerge mainly from the GI tract,
pancreas and respiratory tract. The incidence of NETs has increased more than sixfold in the …

Molecular imaging with 68Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours

D Kaemmerer, L Peter, A Lupp, S Schulz… - European journal of …, 2011 - Springer
Purpose Somatostatin receptors (SSTR) are known for an overexpression in
gastroenteropancreatic neuroendocrine tumours (GEP-NET). The aim of the present study …

68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors

V Ambrosini, D Campana, L Bodei… - Journal of Nuclear …, 2010 - Soc Nuclear Med
Several authors reported the superiority of 68Ga-DOTANOC PET/CT to conventional
imaging (CI) for the assessment of neuroendocrine tumors (NET). However, the detection of …

[HTML][HTML] Changing paradigms with molecular imaging of neuroendocrine tumors

MS Hofman, RJ Hicks - Discovery medicine, 2012 - discoverymedicine.com
Molecular imaging is changing diagnostic and treatment paradigms in patients with
neuroendocrine tumors through its ability to non-invasively characterize disease …

68Ga-DOTATOC imaging of neuroendocrine tumors: a systematic review and metaanalysis

MM Graham, X Gu, T Ginader, P Breheny… - Journal of Nuclear …, 2017 - Soc Nuclear Med
68Ga-DOTATOC, a somatostatin receptor–targeted ligand, has been used clinically in
Europe over the past decade for imaging neuroendocrine tumors (NETs). It appears to be …

Effect of peptide receptor radionuclide therapy on somatostatin receptor status and glucose metabolism in neuroendocrine tumors: intraindividual comparison of Ga …

S Oh, V Prasad, DS Lee… - International journal of …, 2011 - Wiley Online Library
The heterogeneous nature of the neuroendocrine tumors (NET) makes it challenging to find
one uniformly applicable management protocol which is especially true for diagnosis. The …